EcoDrugPlus

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSLOCG00000015613
Gene Symbol: IKBKB
1 Cross references
199 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSLOCG00000015544
Gene Symbol: IMPDH1
4 Cross references
331 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSLOCG00000005346
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSLOCG00000014435
Gene Symbol: IGF1R
3 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSLOCG00000004179
Gene Symbol: INSR
3 Cross references
287 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSLOCG00000013257
Gene Symbol: ITGA2B
3 Cross references
190 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSLOCG00000006512
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSLOCG00000006805
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSLOCG00000000819
Gene Symbol: ITGB1
3 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSLOCG00000011968
Gene Symbol: ITGB3
3 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSLOCG00000002706
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSLOCG00000008636
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).